Genomic Vision SA
PAR:GV

Watchlist Manager
Genomic Vision SA Logo
Genomic Vision SA
PAR:GV
Watchlist
Price: 0.0018 EUR Market Closed
Market Cap: 694.6k EUR

Wall Street
Price Targets

GV Price Targets Summary
Genomic Vision SA

There are no price targets for GV.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Genomic Vision SA Competitors:
Price Targets
SNDX
Syndax Pharmaceuticals Inc
90% Upside
CPRX
Catalyst Pharmaceuticals Inc
44% Upside
MDXH
MDxHealth SA
111% Upside
AZT
Arcticzymes Technologies ASA
54% Upside
XFOR
X4 Pharmaceuticals Inc
87% Upside
300601
Shenzhen Kangtai Biological Products Co Ltd
32% Upside
RIGL
Rigel Pharmaceuticals Inc
6% Upside
ABNX
Abionyx Pharma SA
213% Upside

Revenue
Forecast

Revenue Estimate
Genomic Vision SA

For the last 8 years the compound annual growth rate for Genomic Vision SA's revenue is -14%. The projected CAGR for the next 4 years is 19%.

-14%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-24%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Genomic Vision SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Genomic Vision SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-99%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GV's stock price target?
Not Available

GV doesn't have any price targets made by Wall Street professionals.

What is Genomic Vision SA's Revenue forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for Genomic Vision SA's revenue is -14%. The projected CAGR for the next 4 years is 19%.

Back to Top